Novo Nordisk diabetes drug fails to help heart failure -study
November 08, 2015 at 15:45 PM EST
ORLANDO, Nov 8 (Reuters) - The Novo Nordisk diabetes drug Victoza failed to improve clinical stability or delay death in patients suffering from advanced heart failure, researchers reported at a medical meeting on Sunday.
